Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process
Key points FMECA is a proactive risk assessment tool that has proved useful in identifying potential failures in the process of prescribing and administering cancer treatments, which is a high-risk process. The analysis evidenced 22 failures modes, distributed over the various phases of the process....
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_539dcebae2e84d85b668e53593e7d46a | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Alessandra Buja |e author |
| 700 | 1 | 0 | |a Giuseppe De Luca |e author |
| 700 | 1 | 0 | |a Ketti Ottolitri |e author |
| 700 | 1 | 0 | |a Elena Marchi |e author |
| 700 | 1 | 0 | |a Francesco Paolo De Siena |e author |
| 700 | 1 | 0 | |a Giovanni Leone |e author |
| 700 | 1 | 0 | |a Pietro Maculan |e author |
| 700 | 1 | 0 | |a Umberto Bolzonella |e author |
| 700 | 1 | 0 | |a Riccardo Caberlotto |e author |
| 700 | 1 | 0 | |a Giovanni Cappella |e author |
| 700 | 1 | 0 | |a Giulia Grotto |e author |
| 700 | 1 | 0 | |a Gaia Lattavo |e author |
| 700 | 1 | 0 | |a Benedetta Sforzi |e author |
| 700 | 1 | 0 | |a Giovanni Venturato |e author |
| 700 | 1 | 0 | |a Anna Maria Saieva |e author |
| 700 | 1 | 0 | |a Vincenzo Baldo |e author |
| 245 | 0 | 0 | |a Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration process |
| 260 | |b Taylor & Francis Group, |c 2023-01-01T00:00:00Z. | ||
| 500 | |a 10.1186/s40545-023-00512-9 | ||
| 500 | |a 2052-3211 | ||
| 520 | |a Key points FMECA is a proactive risk assessment tool that has proved useful in identifying potential failures in the process of prescribing and administering cancer treatments, which is a high-risk process. The analysis evidenced 22 failures modes, distributed over the various phases of the process. In order to reduce the likelihood of the cause, or to improve the chances of a failure mode being detected, this work identified a number of recommendations to be adopted in the administration of cancer treatment in an outpatient setting. | ||
| 546 | |a EN | ||
| 690 | |a Patient safety | ||
| 690 | |a Proactive management | ||
| 690 | |a Chemotherapy administration | ||
| 690 | |a Cancer treatment | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Pharmaceutical Policy and Practice, Vol 16, Iss 1, Pp 1-8 (2023) | |
| 787 | 0 | |n https://doi.org/10.1186/s40545-023-00512-9 | |
| 787 | 0 | |n https://doaj.org/toc/2052-3211 | |
| 856 | 4 | 1 | |u https://doaj.org/article/539dcebae2e84d85b668e53593e7d46a |z Connect to this object online. |